You will automatically be redirected in 10 seconds. Or, you can click the link below:

https://www.prnewswire.com/news-releases/armata-pharmaceuticals-receives-3-7-million-in-additional-non-dilutive-funding-from-us-department-of-war-to-support-advancement-of-ap-sa02-phase-3-development-302886960.html